Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015

Stavudine (D4T), zidovudine (AZT), and tenofovir (TDF) along with lamivudine (3TC) are the most widely used HIV treatment regimens in China. China's National Free Antiretroviral Treatment Programme (NFATP) has replaced D4T with AZT or TDF in the standard first-line regimens since 2010. Few stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Pengtao, Liao, Lingjie, Xu, Wei, Yan, Jing, Zuo, Zhongbao, Leng, Xuebing, Wang, Jing, Kan, Wei, You, Yinghui, Xing, Hui, Ruan, Yuhua, Shao, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320000/
https://www.ncbi.nlm.nih.gov/pubmed/30558015
http://dx.doi.org/10.1097/MD.0000000000013555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320000/
https://www.ncbi.nlm.nih.gov/pubmed/30558015
http://dx.doi.org/10.1097/MD.0000000000013555

Ejemplares similares